Cary J. Claiborne
Chief Executive Officer, Director · ADIAL PHARMACEUTICALS, INC.
Individual
- 2024
- Apr 9, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cary J. Claiborne files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Coastlands Capital LP - $106K in ADIL purchases and sales in the last 12 months
- Wendy B. Young - $100K in ADIL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cary J. Claiborne?
Cary J. Claiborne is a corporate insider, tracked as Chief Executive Officer, Director of ADIAL PHARMACEUTICALS, INC. (ADIL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Cary J. Claiborne last file a Form 4?
The most recent primary Form 4 on record is dated 9 April 2026, one of 2 filings going back to 2024.
